Arthritis

(Early) Rheumatoid Arthritis
This research line focusses on the early detection and treatment of inflammatory arthritis.

Treatment strategies in Arthritis
Data gathered in this research line is used to study the effect of treatment with biologic and conventional synthetic DMARDs and the effect of tapering medication.

Psoriatic Arthritis
In this research line Psoriatic Arthritis is studied using data of the Dutch south west Psoriatic Arthritis Registry (DEPAR and STAMP).

(Early) Rheumatoid Arthritis
CSA

Treatment strategies in Arthritis
ChronIA
IMID registry
PRIMERA

Psoriatic Arthritis
DEPAR
STAMP

Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study van Mulligen et al. Annals of the Rheumatic Diseases 2019; 78(6):746-753

Comparison of disease activity measures in early psoriatic arthritis in usual care 
Wervers K et al. Rheumatology 2019; pii: kez215

Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study
Kasiem FR et al. Scandinavian Journal of Rheumatology; Volume 50, 2021 - Issue 2

The likelihood of attaining and maintaining DMARD-free remission for various (rheumatoid) arthritis phenotypes
Luurssen-Masurel N et al. Rheumatology; 05 August 2021

Prof. Annette van der Helm-van Mil, MD PhD

Pascal de Jong, MD PhD

Philomine van Pelt, MD PhD

Marijn Vis, MD PhD

Annelieke Pasma, PhD

Elise van Mulligen, MSc PhD

Kim Wilhelm-de Jong

Anke Nijs

Fazira Kasiem, MD

Judith Heutz, MD

Sanne Boeren, MD

Selinde Snoeck Henkemans, MD

Patty de Groot, MSc

Agnes Looijen, MD

Zohra Layegh, MD

Ron Buijs